STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS
The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodi...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | EREN RACHEL O'CONNOR SANDRA MISRA HEMANT KUMAR GOWAN WALTER G. JR DAGAN SHLOMO |
description | The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20070122554A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20070122554A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20070122554A3</originalsourceid><addsrcrecordid>eNrjZDAPDnF08vTxjHJ1UXD0C_HU9XANcAzxDPEMVnBS0PBwCtMECzv5u0QquPkH-Yb6AGX9_YJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8d5CRgYG5gaGRkampiaMxcaoAzbgo8Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><source>esp@cenet</source><creator>EREN RACHEL ; O'CONNOR SANDRA ; MISRA HEMANT KUMAR ; GOWAN WALTER G. JR ; DAGAN SHLOMO</creator><creatorcontrib>EREN RACHEL ; O'CONNOR SANDRA ; MISRA HEMANT KUMAR ; GOWAN WALTER G. JR ; DAGAN SHLOMO</creatorcontrib><description>The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071231&DB=EPODOC&CC=KR&NR=20070122554A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071231&DB=EPODOC&CC=KR&NR=20070122554A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>EREN RACHEL</creatorcontrib><creatorcontrib>O'CONNOR SANDRA</creatorcontrib><creatorcontrib>MISRA HEMANT KUMAR</creatorcontrib><creatorcontrib>GOWAN WALTER G. JR</creatorcontrib><creatorcontrib>DAGAN SHLOMO</creatorcontrib><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><description>The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPDnF08vTxjHJ1UXD0C_HU9XANcAzxDPEMVnBS0PBwCtMECzv5u0QquPkH-Yb6AGX9_YJ5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8d5CRgYG5gaGRkampiaMxcaoAzbgo8Q</recordid><startdate>20071231</startdate><enddate>20071231</enddate><creator>EREN RACHEL</creator><creator>O'CONNOR SANDRA</creator><creator>MISRA HEMANT KUMAR</creator><creator>GOWAN WALTER G. JR</creator><creator>DAGAN SHLOMO</creator><scope>EVB</scope></search><sort><creationdate>20071231</creationdate><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><author>EREN RACHEL ; O'CONNOR SANDRA ; MISRA HEMANT KUMAR ; GOWAN WALTER G. JR ; DAGAN SHLOMO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20070122554A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>EREN RACHEL</creatorcontrib><creatorcontrib>O'CONNOR SANDRA</creatorcontrib><creatorcontrib>MISRA HEMANT KUMAR</creatorcontrib><creatorcontrib>GOWAN WALTER G. JR</creatorcontrib><creatorcontrib>DAGAN SHLOMO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>EREN RACHEL</au><au>O'CONNOR SANDRA</au><au>MISRA HEMANT KUMAR</au><au>GOWAN WALTER G. JR</au><au>DAGAN SHLOMO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS</title><date>2007-12-31</date><risdate>2007</risdate><abstract>The present invention provides liquid formulations of antibodies or fragments thereof that specifically bind to a hepatitis B virus (HBV) antigen, which formulations exhibit stability, low to undetectable levels of aggregations, and very little to no loss of the biological activities of the antibodies or antibody fragments, even during long periods of storage. Furthermore, the invention provides methods of preventing, treating or ameliorating one or more symptoms associated with HBV infection utilizing the liquid formulations of the present invention.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_KR20070122554A |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | STABILIZED ANTI-HEPATITIS B (HBV) ANTIBODY FORMULATIONS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A00%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=EREN%20RACHEL&rft.date=2007-12-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20070122554A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |